1Lew SQ,Gruia A.Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis[J]. Perit Dial Int,2013,33(1):101-102.
2Cho KH,DO JY,Park JW,et al. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients:a single centre experience[J]. Nephrology(Carlton),2012,17(8): 760-766.
8Chung S H, Stenvinkel P, Bergstrom J, et al. Biocom- patibility of new peritoneal dialysis solutions: what can we hope to achieve?[J].Perit Dial Int, 2000,20 (Suppl 5) :S57-S67.
10Davies S J, Garcia Lopez E, Woodrow G, et al. Longitu- dinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in pa tients randomized to glucose or icodextrin for the long exchange[J]. Nephrol Dial Transplant, 2008, 23 ( 9 ) : 2982-2988.
